|
| Cognitive dysfunction and glycemic management associated with type 2 diabetes mellitus |
| Received:June 05, 2021 |
| View Full Text View/Add Comment Download reader |
| DOI：10.11915/j.issn.1671-5403.2022.07.118 |
| Key words:cognitive dysfunction type 2 diabetes mellitus HbA1c glycemic management This work was supported by the National Natural Science Foundation of China |
| Author Name | Affiliation | E-mail | | MA Fan-Yuan | Department of Geriatrics, First Affiliated Hospital of Air Force Medical University, Xi′an 710032, China | | | WU Li-Ping | Department of Geriatrics, First Affiliated Hospital of Air Force Medical University, Xi′an 710032, China | | | WANG Xiao-Ming | Department of Geriatrics, First Affiliated Hospital of Air Force Medical University, Xi′an 710032, China | | | ZHANG Hua | Department of Geriatrics, First Affiliated Hospital of Air Force Medical University, Xi′an 710032, China | zhanghua77@fmmu.edu.cn |
|
| Hits: 90 |
| Download times: 54 |
| Abstract: |
| Cognitive dysfunction, including mild cognitive impairment, Alzheimer′s disease and dementia, is increasingly recognized as significant comorbidities or complications of type 2 diabetes mellitus (T2DM), disrupting glycemic management. This paper reviews the association between T2DM and cognitive dysfunction and glycemic control, screening and diagnosis of risk factors, T2DM management in patients with cognitive dysfunction (considering advanced age and frailty in older adults), and emerging preventative therapies. Satisfactory glycemic management and early cognitive testing are essential components of T2DM management, and persona-lized strategies should be implemented, including patient education, glycemic monitoring, and appropriate dietary and medication adjustments based on daily conditions (including physical exercises). |
| Close |
|
|
|